Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients: a Cluster Randomised Clinical Trial
Xijing Hospital
1,200 participants
Jun 20, 2025
INTERVENTIONAL
Conditions
Summary
The objective of this cluster randomized controlled trial is to evaluate the effectiveness of a pharmacist-led multifaceted intensive blood pressure intervention on poorly controlled hypertensive patients in phase 1 (1 month, 3 months, 6 months, 12 months) and phase 2 (24 months) post randomization.
Eligibility
Inclusion Criteria6
- \) age 18-80 years;
- \) patients with hypertension (diagnostic criteria: defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg according to the "Guidelines for the prevention and treatment of hypertension in China in 2023", based on the blood pressure measurement of three times on different days), who are currently taking anti-hypertensive medication and are judged by the research physician to have poor blood pressure control;
- \) able to use smartphones and WeChat proficiently, and can communicate and upload pictures proficiently;
- \) able to take care of yourself and communicate normally, and willing to cooperate with the research physician to complete the study and follow-up;
- \) permanent residents of the city where the center is located;
- \) voluntarily participate and sign the informed consent form
Exclusion Criteria4
- \) patients with advanced disease (such as patients undergoing dialysis or liver failure), or with a life expectancy of less than 2 years as determined by the research physician;
- \) combined with psychiatric disease, cognitive impairment, communication disorder, or inability to cooperate with the researchers;
- \) combined with cerebrovascular disease, stroke, severe liver and kidney dysfunction, severe heart failure, cancer and history of organ transplantation, etc.;
- \) patients who are pregnant, breastfeeding, or planning to conceive in the next 2 years.
Interventions
Based on the blood pressure management model of pharmacist-led multifaceted intervention, clinical pharmacists who have received unified training provide pharmaceutical intervention and lifestyle guidance to subjects in the intervention group according to standard protocol. Pharmaceutical interventions include health education, medication adherence (medication consultation, medication reminder), medication reorganization, and rational use of medication. At the same time, clinical pharmacists supervise the subjects to change their lifestyle (including reasonable diet, quitting smoking and drinking, moderate exercise, weight control and ensuring sleep, etc.), and guide the subjects to conduct home blood pressure monitoring.
The subjects receive conventional hypertension health education, standard blood pressure measurement training and regular follow-up in the control group.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06558877